Free Trial

Nisa Investment Advisors LLC Has $96.80 Million Holdings in CME Group Inc. (NASDAQ:CME)

CME Group logo with Finance background

Nisa Investment Advisors LLC boosted its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 2.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 364,899 shares of the financial services provider's stock after buying an additional 7,600 shares during the quarter. Nisa Investment Advisors LLC owned approximately 0.10% of CME Group worth $96,804,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of CME. Bank Pictet & Cie Europe AG increased its holdings in CME Group by 29.0% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 86,941 shares of the financial services provider's stock valued at $20,190,000 after buying an additional 19,533 shares during the last quarter. Proficio Capital Partners LLC purchased a new position in shares of CME Group during the fourth quarter worth about $268,000. Simplicity Wealth LLC grew its holdings in shares of CME Group by 13.3% during the fourth quarter. Simplicity Wealth LLC now owns 1,198 shares of the financial services provider's stock worth $278,000 after purchasing an additional 141 shares during the last quarter. Isthmus Partners LLC purchased a new position in shares of CME Group during the fourth quarter worth about $200,000. Finally, Independent Advisor Alliance grew its holdings in shares of CME Group by 23.7% during the fourth quarter. Independent Advisor Alliance now owns 8,827 shares of the financial services provider's stock worth $2,050,000 after purchasing an additional 1,692 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.

Insider Buying and Selling at CME Group

In other news, Director Phyllis M. Lockett sold 1,060 shares of the business's stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $277.88, for a total transaction of $294,552.80. Following the sale, the director owned 3,108 shares in the company, valued at $863,651.04. The trade was a 25.43% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William R. Shepard purchased 256 shares of the business's stock in a transaction dated Wednesday, June 25th. The shares were purchased at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the acquisition, the director directly owned 258,196 shares of the company's stock, valued at $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders sold 13,400 shares of company stock valued at $3,680,610. Corporate insiders own 0.30% of the company's stock.

CME Group Price Performance

Shares of NASDAQ:CME traded down $0.45 during trading on Thursday, reaching $275.19. The company had a trading volume of 1,602,078 shares, compared to its average volume of 2,197,116. The firm's fifty day moving average is $276.69 and its 200 day moving average is $258.98. The firm has a market capitalization of $99.17 billion, a PE ratio of 27.69, a price-to-earnings-growth ratio of 3.74 and a beta of 0.44. CME Group Inc. has a twelve month low of $193.17 and a twelve month high of $290.79. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The business had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same period in the prior year, the business earned $2.50 earnings per share. The business's quarterly revenue was up 10.4% on a year-over-year basis. On average, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.82%. The ex-dividend date of this dividend was Monday, June 9th. CME Group's dividend payout ratio is presently 50.30%.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. Citigroup raised their price objective on CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a report on Thursday, July 3rd. Oppenheimer raised their price objective on CME Group from $282.00 to $300.00 and gave the stock an "outperform" rating in a report on Wednesday, June 4th. Piper Sandler raised their price objective on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a report on Tuesday, April 8th. Royal Bank Of Canada reaffirmed a "sector perform" rating and set a $269.00 price objective on shares of CME Group in a report on Thursday, April 3rd. Finally, Keefe, Bruyette & Woods increased their target price on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a research note on Thursday, April 24th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $260.93.

Read Our Latest Stock Report on CME

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines